BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31081078)

  • 21. High Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Expression Promotes Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer via ERK/Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway.
    Liu C; Li H; Jia J; Ruan X; Liu Y; Zhang X
    Med Sci Monit; 2019 Jul; 25():5143-5149. PubMed ID: 31293277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway.
    Gan Q; Huang X; Zhao W; Liu H; Xu Y; Zhang X; Cheng J; Chen R
    BMC Cancer; 2023 Apr; 23(1):364. PubMed ID: 37081411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
    Xu DF; Wang LS; Zhou JH
    Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin‑17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer.
    Lv Q; Wu K; Liu F; Wu W; Chen Y; Zhang W
    Int J Oncol; 2018 Oct; 53(4):1809-1817. PubMed ID: 30066843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA CASC2 alleviates the growth, migration and invasion of oral squamous cell carcinoma via downregulating CDK1.
    Xing HB; Qiu HM; Li Y; Dong PF; Zhu XM
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4777-4783. PubMed ID: 31210307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of lncRNA CASC2 Suppresses Cell Proliferation and Metastasis of Breast Cancer via Inactivation of the TGF-β Signaling Pathway.
    Zhang Y; Zhu M; Sun Y; Li W; Wang Y; Yu W
    Oncol Res; 2019 Feb; 27(3):379-387. PubMed ID: 29523222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
    Dai SG; Guo LL; Xia X; Pan Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):486-495. PubMed ID: 30720155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.
    Li Y; Xiao M; Guo F
    Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
    Gao X; Du H; Zhang R; Li C; Wang H; Xuan Q; Liu D
    J Cell Physiol; 2019 Jun; 234(6):9008-9018. PubMed ID: 30362539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR-362-5p/Nf-κB axis.
    Zhao L; Zhang Y; Zhang Y
    J Cell Physiol; 2018 Oct; 233(10):6661-6670. PubMed ID: 29319182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA CASC2 inhibits metastasis and epithelial to mesenchymal transition of lung adenocarcinoma via suppressing SOX4.
    Wang D; Gao ZM; Han LG; Xu F; Liu K; Shen Y
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4584-4590. PubMed ID: 29131257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA CASC2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway.
    Li P; Xue WJ; Feng Y; Mao QS
    Am J Transl Res; 2016; 8(8):3522-9. PubMed ID: 27648142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.
    Dai W; Mu L; Cui Y; Li Y; Chen P; Xie H; Wang X
    Med Sci Monit; 2019 Jan; 25():730-738. PubMed ID: 30681073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long non-coding RNA (lncRNA) cancer susceptibility candidate 2c (CASC2c) on proliferation, metastasis and drug resistance of non-small cell lung cancer (NSCLC) cells through ERK1/2 and β-catenin signaling pathways.
    Tong L; Wu W
    Pathol Res Pract; 2019 Sep; 215(9):152522. PubMed ID: 31300295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
    Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
    Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression.
    Qu B; Zhao AH; Nie XZ; Sui R; Du MM; Jiang L; Wang HL
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4680-4687. PubMed ID: 31210294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells.
    Cao Y; Xu R; Xu X; Zhou Y; Cui L; He X
    Mol Med Rep; 2016 Jul; 14(1):1019-25. PubMed ID: 27222255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.
    Hua F; Liu S; Zhu L; Ma N; Jiang S; Yang J
    Biomed Pharmacother; 2017 Aug; 92():1128-1134. PubMed ID: 28628975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. lncRNA CASC2/miR‑18a‑5p axis regulates the malignant potential of nasopharyngeal carcinoma by targeting RBBP8.
    Miao WJ; Yuan DJ; Zhang GZ; Liu Q; Ma HM; Jin QQ
    Oncol Rep; 2019 Mar; 41(3):1797-1806. PubMed ID: 30569153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.
    Guan MM; Rao QX; Huang ML; Wang LJ; Lin SD; Chen Q; Liu CH
    Med Sci Monit; 2019 Oct; 25():8131-8141. PubMed ID: 31663517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.